Member Exclusive NEWS ROUND-UP

Cell therapy weekly: positive results for diabetic retinopathy phase III trial

This week: phase III diabetic retinopathy trial meets 24-week primary endpoint and progress on manufacturing universal donor cell therapy.

Go to the profile of RegMedNet
Mar 22, 2018

Please sign in or register for FREE

No comments yet.